MarketPeel
Insider Trading Intelligence
Pricing
…
RH

Rocio Martin Hoyos

RNA
CHIEF STRATEGY OFFICER · ATRIUM THERAPEUTICS, INC. · CIK 0002107515
FILING MIX · LIFETIME100%/0%
BUYS
2
SELLS
0
TOTAL VALUE
$0
COMPANIES
1
ACTIVE SINCE
Apr 2026
HOLDINGS NOW
60,000
AVG SELL PX
—
TRADE KIND
SHOWING 2 / 2
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
No backtest data available for Rocio Martin Hoyos. Backtests are computed for purchase (P) and sale (S) transactions with resolvable price history.
Holdings over time
RNA · 60,000 shares · as of Apr 20, 2026
015,00030,00045,00060,000SHARES HELD
Trading cadence · quarterly flow
BUY ● SELL ●
2026
FLOW · 2 buys / 0 sellsCOVERAGE · 1 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILED
RNA
ATRIUM THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
30,000——46,660Apr 20, 2026Apr 22, 2026 ↗
RNA
ATRIUM THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
60,000——60,000Apr 20, 2026Apr 22, 2026 ↗
Other insiders · RNA
Loading peer insiders…
About this filer
CIK 0002107515
ROLE
Chief Strategy Officer
PRIMARY
RNA
COMPANIES
1
ACTIVE SINCE
Apr 2026
MARKETPEEL · /INSIDER/0002107515DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

The morning brief, before the bell.

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback